BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37385981)

  • 1. External validation of a risk model predicting failure of salvage focal ablation for prostate cancer.
    Light A; Peters M; Reddy D; Kanthabalan A; Otieno M; Pavlou M; Omar R; Adeleke S; Giganti F; Brew-Graves C; Williams NR; Emara A; Haroon A; Latifoltojar A; Sidhu H; Freeman A; Orczyk C; Nikapota A; Dudderidge T; Hindley RG; Virdi J; Arya M; Payne H; Mitra AV; Bomanji J; Winkler M; Horan G; Moore C; Emberton M; Punwani S; Ahmed HU; Shah TT
    BJU Int; 2023 Nov; 132(5):520-530. PubMed ID: 37385981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and internal validation of prediction models for biochemical failure and composite failure after focal salvage high intensity focused ultrasound for local radiorecurrent prostate cancer: Presentation of risk scores for individual patient prognoses.
    Peters M; Kanthabalan A; Shah TT; McCartan N; Moore CM; Arya M; van der Voort van Zyp JR; Moerland MA; Hindley RG; Emberton M; Ahmed HU
    Urol Oncol; 2018 Jan; 36(1):13.e1-13.e10. PubMed ID: 28927782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After Radiotherapy.
    Shah TT; Kanthabalan A; Otieno M; Pavlou M; Omar R; Adeleke S; Giganti F; Brew-Graves C; Williams NR; Grierson J; Miah H; Emara A; Haroon A; Latifoltojar A; Sidhu H; Clemente J; Freeman A; Orczyk C; Nikapota A; Dudderidge T; Hindley RG; Virdi J; Arya M; Payne H; Mitra A; Bomanji J; Winkler M; Horan G; Moore CM; Emberton M; Punwani S; Ahmed HU
    Eur Urol; 2022 Jun; 81(6):598-605. PubMed ID: 35370021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial.
    Light A; Kanthabalan A; Otieno M; Pavlou M; Omar R; Adeleke S; Giganti F; Brew-Graves C; Williams NR; Emara A; Haroon A; Latifoltojar A; Sidhu H; Freeman A; Orczyk C; Nikapota A; Dudderidge T; Hindley RG; Virdi J; Arya M; Payne H; Mitra AV; Bomanji J; Winkler M; Horan G; Moore CM; Emberton M; Punwani S; Ahmed HU; Shah TT
    Eur Urol; 2024 Jan; 85(1):35-46. PubMed ID: 37778954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer.
    Kanthabalan A; Peters M; Van Vulpen M; McCartan N; Hindley RG; Emara A; Moore CM; Arya M; Emberton M; Ahmed HU
    BJU Int; 2017 Aug; 120(2):246-256. PubMed ID: 28258616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage high-intensity focused ultrasound for locally recurrent prostate cancer after low-dose-rate brachytherapy: oncological and functional outcomes.
    Hostiou T; Gelet A; Chapelon JY; Rouvière O; Mège-Lechevalier F; Lafon C; Tonoli-Catez H; Badet L; Crouzet S
    BJU Int; 2019 Nov; 124(5):746-757. PubMed ID: 31148367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer.
    Chesnut GT; Tin AL; Sivaraman A; Takeda T; Lee T; Fainberg J; Benfante N; Sjoberg DD; Vargas HA; Fine SW; Scardino PT; Eastham JA; Coleman JA; Touijer KA; Zelefsky MJ; Ehdaie B
    Urol Oncol; 2021 Aug; 39(8):495.e17-495.e24. PubMed ID: 33583697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation.
    Ramsay CR; Adewuyi TE; Gray J; Hislop J; Shirley MD; Jayakody S; MacLennan G; Fraser C; MacLennan S; Brazzelli M; N'Dow J; Pickard R; Robertson C; Rothnie K; Rushton SP; Vale L; Lam TB
    Health Technol Assess; 2015 Jul; 19(49):1-490. PubMed ID: 26140518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
    Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT
    Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER).
    Valle LF; Lehrer EJ; Markovic D; Elashoff D; Levin-Epstein R; Karnes RJ; Reiter RE; Rettig M; Calais J; Nickols NG; Dess RT; Spratt DE; Steinberg ML; Nguyen PL; Davis BJ; Zaorsky NG; Kishan AU
    Eur Urol; 2021 Sep; 80(3):280-292. PubMed ID: 33309278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External validation of biochemical recurrence definition to predict oncologic outcomes following focal therapy for localized prostate cancer using high intensity focused ultrasound.
    Mattlet A; Limani K; Alexandre P; Hawaux E; Abou Zahr R; Aoun F; Diamand R
    Prostate; 2023 Dec; 83(16):1564-1571. PubMed ID: 37574824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can quantitative analysis of multi-parametric MRI independently predict failure of focal salvage HIFU therapy in men with radio-recurrent prostate cancer?
    Rakauskas A; Shah TT; Peters M; Randeva JS; Hosking-Jervis F; Schmainda MJ; Orczyck C; Emberton M; Arya M; Moore C; Ahmed HU
    Urol Oncol; 2021 Dec; 39(12):830.e1-830.e8. PubMed ID: 34049783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy.
    Kimura M; Mouraviev V; Tsivian M; Mayes JM; Satoh T; Polascik TJ
    BJU Int; 2010 Jan; 105(2):191-201. PubMed ID: 19583717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the cryo on-line data registry.
    Li YH; Elshafei A; Agarwal G; Ruckle H; Powsang J; Jones JS
    Prostate; 2015 Jan; 75(1):1-7. PubMed ID: 25283814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical Trial.
    Murgic J; Morton G; Loblaw A; D'Alimonte L; Ravi A; Wronski M; Davidson M; Haider M; Commisso K; Zhang L; Chung HT
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):561-567. PubMed ID: 30244878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal MRI-Guided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer.
    Maenhout M; Peters M; van Vulpen M; Moerland MA; Meijer RP; van den Bosch MAAJ; Nguyen PL; Frank SJ; van der Voort van Zyp JRN
    Technol Cancer Res Treat; 2017 Dec; 16(6):1194-1201. PubMed ID: 29333958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness Analyses of Salvage Prostatectomy and Salvage Radiotherapy Outcomes Following Focal or Whole-Gland Ablative Therapy (High-Intensity Focused Ultrasound, Cryotherapy or Electroporation) for Localised Prostate Cancer.
    Nathan A; Ng A; Mitra A; Sooriakumaran P; Davda R; Patel S; Fricker M; Kelly J; Shaw G; Rajan P; Sridhar A; Nathan S; Payne H
    Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):e69-e78. PubMed ID: 34740477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of focal salvage ablative therapy in localised radiorecurrent prostate cancer.
    Kanthabalan A; Arya M; Punwani S; Freeman A; Haroon A; Bomanji J; Emberton M; Ahmed HU
    World J Urol; 2013 Dec; 31(6):1361-8. PubMed ID: 24121817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526).
    Crook JM; Zhang P; Pisansky TM; Trabulsi EJ; Amin MB; Bice W; Morton G; Pervez N; Vigneault E; Catton C; Michalski J; Roach M; Beyer D; Jani A; Horwitz E; Donavanik V; Sandler H
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):335-343. PubMed ID: 30312717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and internal validation of a multivariable prediction model for biochemical failure after whole-gland salvage iodine-125 prostate brachytherapy for recurrent prostate cancer.
    Peters M; van der Voort van Zyp JRN; Moerland MA; Hoekstra CJ; van de Pol S; Westendorp H; Maenhout M; Kattevilder R; Verkooijen HM; van Rossum PSN; Ahmed HU; Shah TT; Emberton M; van Vulpen M
    Brachytherapy; 2016; 15(3):296-305. PubMed ID: 26948662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.